Latest It Distribution News

Samuel Terry Asset Management has launched an off-market takeover offer for all Eildon Capital Group stapled securities at A$0.80 per security, representing a notable premium over recent trading prices. The move aims to consolidate ownership and potentially delist Eildon Capital from the ASX.

Memphasys has inked a five-year exclusive distribution agreement with Middle East leader ITL, unlocking a $325,000 initial order for its Felix™ fertility system upon CE Mark approval. This deal opens access to 15 countries and over 350 IVF clinics, setting the stage for rapid regional adoption.

Heartland Group Holdings updates its dividend distribution details for the first half of 2025, confirming an unfranked ordinary dividend and a supplementary dividend with a revised DRP strike price.

Deterra Royalties Limited has updated its dividend announcement, confirming a fully franked ordinary dividend of AUD 0.13 per share for the half-year ending June 2025, alongside a recalculated Dividend Reinvestment Plan price.

Lode Resources has agreed to sell its Webbs Consol Silver Project to Rapid Critical Metals for A$3.75 million cash, 115 million shares, and a 2% royalty, consolidating high-grade silver assets in New South Wales.

Platinum Capital Limited has updated the price for its Dividend Reinvestment Plan (DRP) ahead of its fully franked dividend payment for the six months ending June 2025. The dividend of 3 cents per share will be paid on September 22, with new shares issued under the DRP at a revised price.

Cambium Bio has secured a strategic partnership with French pharmaceutical leader Benta SAS to commercialise its regenerative dry eye treatment, Elate Ocular, across Europe and the Middle East. This follows a second platelet-lysate licensing deal within days, underscoring growing industry confidence in Cambium’s platform.

Lake Resources N.L. has launched a prospectus offering up to 271.7 million new options linked to a recent A$12 million placement, aiming to advance its flagship Kachi lithium project. The options, exercisable at A$0.05 and expiring in three years, await shareholder approval and align management with investors.

Marquee Resources has confirmed consistently high-grade antimony mineralisation at its Mt Clement (Eastern Hills) Project, setting the stage for a maiden JORC resource estimate expected within two weeks.

Botanix Pharmaceuticals’ ECCLOCK® gel, a treatment for excessive sweating, has secured regulatory approval in South Korea, paving the way for a commercial launch in early 2026.

Auric Mining has completed the final toll milling campaign at Jeffreys Find, securing a substantial profit share and setting the stage for expanded operations at its Munda Gold Mine.

Evolution Energy Minerals has announced that its recent entitlement offer is now fully underwritten by Mahe Capital, with key directors participating as sub-underwriters, removing previous minimum subscription conditions.